Myonexus Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Myonexus Therapeutics M&A Summary

Myonexus Therapeutics has acquired 2 companies of its own, including 2 in the last 5 years.

Myonexus Therapeutics has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (50%) and packaging (50%).

Myonexus Therapeutics Ownership

Who owns Myonexus Therapeutics?

Myonexus Therapeutics is owned by Sarepta Therapeutics. It was acquired on February 27, 2019.

Myonexus Therapeutics Business Overview

Where is Myonexus Therapeutics headquartered?

Myonexus Therapeutics is headquartered in New Albany, Ohio.

What sector is Myonexus Therapeutics in?

Myonexus Therapeutics is a life science company.

When was Myonexus Therapeutics founded?

Myonexus Therapeutics was founded in 2017.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Myonexus Therapeutics

8000 Walton Parkway, Suite 255,
New Albany, Ohio 43054
United States,
www.myonexustx.com

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a provider in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics was founded in 2017 and is based in New Albany, Ohio.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - - - - - 2 2
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
SaveWay Compounding Pharmacy 2024-04-10 - Add-on Acquisition
Newark, Delaware · www.savewaypharmacy.com
Creapharm’s Clinical & Commercial Packaging and Bioservices Business 2024-03-15 - Divestiture
Reims, France
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) - - -
Packaging 1 (50%) - - -
Total 2 - - -

By Geo

State/Country Buy Value Sell Value
France 1 - - -
United States 1 - - -
  Delaware 1 - - -
Domestic 1 (50%) - - -
Cross-border 1 (50%) - - -
Total 2 - - -

M&A Connections

Deals
Acquired from
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.